Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | NBM-BMX |
| Synonyms | |
| Therapy Description |
NBM-BMX inhibits histone deacetylase type 8 (HDAC8), which may lead to increased histone acetylation, cell cycle arrest, and apoptosis in tumor cells (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| NBM-BMX | NBM BMX | NBM-BMX inhibits histone deacetylase type 8 (HDAC8), which may lead to increased histone acetylation, cell cycle arrest, and apoptosis in tumor cells (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07136181 | Phase Ib/II | NBM-BMX | Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma (NBM-BMX-UM) | Recruiting | USA | 0 |
| NCT03726294 | Phase I | NBM-BMX | A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Patients With Advanced Cancer | Completed | USA | 0 |